Xeris Biopharma Holdings Inc. (XERS) Debt to Equity Ratio
Xeris Biopharma Holdings Inc. (XERS) debt-to-equity ratio history and balance sheet leverage. Analyze D/E ratio in Excel with MarketXLS.
Debt to Equity Ratio Data
| Period | Debt/Equity |
|---|---|
| 2022-12-31 | 6.62 |
| 2023-03-31 | 9.69 |
| 2023-06-30 | N/A |
| 2023-12-31 | -48.57 |
| 2024-12-31 | -11.91 |
Get Xeris Biopharma Holdings Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Debt_to_Equity_Ratio("XERS", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | XERS | $6.05 | +1.68% | 1.03M |
| 3 | ||||
| 4 | ||||
| 5 |